Imed Infinity Medical-Limited Partnership
Tel Aviv Stock Exchange IMED.TA
Imed Infinity Medical-Limited Partnership Revenue Per Share for the year ending December 31, 2023
Imed Infinity Medical-Limited Partnership Revenue Per Share is NA for the year ending December 31, 2023. Revenue per share indicates revenue generated per share; higher ratios suggest stronger performance and value.
-
Imed Infinity Medical-Limited Partnership Revenue Per Share for the year ending December 31, 2022 was USD 0.05, a 167.17% change year over year.
-
Imed Infinity Medical-Limited Partnership Revenue Per Share for the year ending December 31, 2021 was USD 0.02.
Key data
| Date | Revenue Per Share | Dividend Per Share | Free Cash Flow Per Share | Return on Assets (ROA) |
|---|
Market news
Loading...
Tel Aviv Stock Exchange: IMED.TA
| CEO | Mr. Itay Gal-Or |
| IPO Date | Jan. 4, 2021 |
| Location | Israel |
| Headquarters | Azrieli Tower |
| Employees | 55 |
| Sector | Industrials |
| Industries | |
Description
Imed Infinity Medical-Limited Partnership, a research and development partnership, focuses on investing in research projects and development in the medical field, primarily the digital health field. The company was incorporated in 2020 and is based in Tel Aviv, Israel.
Key trends
Past 5 years
StockViz Staff
January 15, 2025
Any question? Send us an email